ProfileGDS4718 / 1568815_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 48% 41% 31% 47% 39% 44% 31% 26% 43% 43% 42% 35% 42% 41% 40% 38% 30% 40% 42% 40% 39% 37% 43% 36% 43% 41% 44% 60% 53% 47% 30% 40% 29% 39% 28% 43% 36% 38% 31% 34% 35% 35% 33% 50% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4073348
GSM549102patient 115, normal, homogenized [OPG study]5.0591541
GSM549104patient 119, normal, homogenized [OPG study]4.5693731
GSM549108patient 138, normal, homogenized [OPG study]5.4024947
GSM549119patient 077, normal, homogenized [OPG study]4.932639
GSM549133patient 032, cancer, homogenized [OPG study]5.1531944
GSM549139patient 042, cancer, homogenized [OPG study]4.5725731
GSM549099patient 107, normal, homogenized [OPG study]4.4062726
GSM549109patient 139, normal, homogenized [OPG study]5.1425143
GSM549110patient 046, normal, homogenized [OPG study]5.1534443
GSM549114patient 063, normal, homogenized [OPG study]5.0294642
GSM549122patient 082, normal, homogenized [OPG study]4.7812135
GSM549134patient 033, cancer, homogenized [OPG study]5.0957742
GSM549136patient 036, cancer, homogenized [OPG study]4.9675541
GSM549140patient 044, cancer, homogenized [OPG study]4.9711640
GSM549111patient 047, normal, homogenized [OPG study]4.8898338
GSM549113patient 057, normal, homogenized [OPG study]4.4906730
GSM549132patient 031, cancer, homogenized [OPG study]4.9545540
GSM549137patient 038, cancer, homogenized [OPG study]5.0878742
GSM549142patient 047, cancer, homogenized [OPG study]5.1427540
GSM549100patient 110, normal, homogenized [OPG study]4.9636939
GSM549107patient 135, normal, homogenized [OPG study]4.8328337
GSM549115patient 068, normal, homogenized [OPG study]5.0623843
GSM549116patient 072, normal, homogenized [OPG study]4.7579836
GSM549120patient 078, normal, homogenized [OPG study]5.1614543
GSM549131patient 030, cancer, homogenized [OPG study]4.9586941
GSM549118patient 074, normal, homogenized [OPG study]5.20644
GSM549129patient 027, cancer, homogenized [OPG study]6.1730460
GSM549123patient 088, normal, homogenized [OPG study]5.7009753
GSM549124patient 006, cancer, homogenized [OPG study]5.369747
GSM549126patient 015, cancer, homogenized [OPG study]4.5143430
GSM549128patient 025, cancer, homogenized [OPG study]4.9772140
GSM549103patient 117, normal, homogenized [OPG study]4.5655529
GSM549117patient 073, normal, homogenized [OPG study]4.8914139
GSM549138patient 041, cancer, homogenized [OPG study]4.4585128
GSM549141patient 045, cancer, homogenized [OPG study]5.0868743
GSM549130patient 028, cancer, homogenized [OPG study]4.8178736
GSM549101patient 111, normal, homogenized [OPG study]4.9388138
GSM549105patient 128, normal, homogenized [OPG study]4.5986131
GSM549106patient 134, normal, homogenized [OPG study]4.690134
GSM549112patient 048, normal, homogenized [OPG study]4.7629335
GSM549125patient 011, cancer, homogenized [OPG study]4.7675835
GSM549127patient 024, cancer, homogenized [OPG study]4.6694233
GSM549135patient 035, cancer, homogenized [OPG study]5.5083450